These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28716511)

  • 1. An ensemble predictive modeling framework for breast cancer classification.
    Nagarajan R; Upreti M
    Methods; 2017 Dec; 131():128-134. PubMed ID: 28716511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach for deciphering patient-specific variations with application to breast cancer molecular expression profiles.
    Nagarajan R; Upreti M
    J Biomed Inform; 2016 Oct; 63():120-130. PubMed ID: 27477838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical evaluation of network and pathway-based classifiers for outcome prediction in breast cancer.
    Staiger C; Cadot S; Kooter R; Dittrich M; Müller T; Klau GW; Wessels LF
    PLoS One; 2012; 7(4):e34796. PubMed ID: 22558100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ensemble machine learning approach to predict survival in breast cancer.
    Djebbari A; Liu Z; Phan S; Famili F
    Int J Comput Biol Drug Des; 2008; 1(3):275-94. PubMed ID: 20054993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDM-PhyChm-Ens: intelligent decision-making ensemble methodology for classification of human breast cancer using physicochemical properties of amino acids.
    Ali S; Majid A; Khan A
    Amino Acids; 2014 Apr; 46(4):977-93. PubMed ID: 24390396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.
    Gong IY; Fox NS; Huang V; Boutros PC
    PLoS One; 2018; 13(9):e0204123. PubMed ID: 30216362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
    Milioli HH; Vimieiro R; Riveros C; Tishchenko I; Berretta R; Moscato P
    PLoS One; 2015; 10(7):e0129711. PubMed ID: 26132585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model-free ensemble method for class prediction with application to biomedical decision making.
    Kodell RL; Pearce BA; Baek S; Moon H; Ahn H; Young JF; Chen JJ
    Artif Intell Med; 2009 Jul; 46(3):267-76. PubMed ID: 19081231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer classification from gene expression data by NPPC ensemble.
    Ghorai S; Mukherjee A; Sengupta S; Dutta PK
    IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(3):659-71. PubMed ID: 20479504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of network features for the prediction of breast cancer metastasis.
    Adnan N; Liu Z; Huang THM; Ruan J
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):40. PubMed ID: 32241278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hybrid cost-sensitive ensemble for imbalanced breast thermogram classification.
    Krawczyk B; Schaefer G; Woźniak M
    Artif Intell Med; 2015 Nov; 65(3):219-27. PubMed ID: 26319694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining clustering and classification ensembles: A novel pipeline to identify breast cancer profiles.
    Agrawal U; Soria D; Wagner C; Garibaldi J; Ellis IO; Bartlett JMS; Cameron D; Rakha EA; Green AR
    Artif Intell Med; 2019 Jun; 97():27-37. PubMed ID: 31202397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor classification by combining PNN classifier ensemble with neighborhood rough set based gene reduction.
    Wang SL; Li X; Zhang S; Gui J; Huang DS
    Comput Biol Med; 2010 Feb; 40(2):179-89. PubMed ID: 20044083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EARN: an ensemble machine learning algorithm to predict driver genes in metastatic breast cancer.
    Mirsadeghi L; Haji Hosseini R; Banaei-Moghaddam AM; Kavousi K
    BMC Med Genomics; 2021 May; 14(1):122. PubMed ID: 33962648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Specific Variations in Biomarkers across Gingivitis and Periodontitis.
    Nagarajan R; Miller CS; Dawson D; Al-Sabbagh M; Ebersole JL
    PLoS One; 2015; 10(9):e0136792. PubMed ID: 26407063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-driven integrated classification of breast cancer validated in over 7,500 samples.
    Ali HR; Rueda OM; Chin SF; Curtis C; Dunning MJ; Aparicio SA; Caldas C
    Genome Biol; 2014 Aug; 15(8):431. PubMed ID: 25164602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
    Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
    J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular classification of breast cancer: what the pathologist needs to know.
    Rakha EA; Green AR
    Pathology; 2017 Feb; 49(2):111-119. PubMed ID: 28040199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.